Treatment of acute post-surgical infection of joint arthroplasty.

The best antibiotic regimen for acute prosthetic joint infection, treated without removal of the implant, has not been well-defined. This study describes the use of a protocol based on oral rifampicin combinations to treat 47 cases that were followed prospectively for a 2-year period. The regimen used most commonly was levofloxacin 500 mg/24 h plus rifampicin 600 mg/24 h for a mean duration of 2.7 +/- 1 months. The cure rate was 76.9%, and the only independent risk-factor associated with treatment failure was infection caused by methicillin-resistant Staphylococcus aureus or Enterococcus spp. (OR 17.6, p 0.003). Overall, the results suggested that use of oral antibiotics, including rifampicin, for 2-3 months was a good treatment option.

[1]  J. Dillner,et al.  Chlamydia trachomatis infection and persistence of human papillomavirus , 2005, International journal of cancer.

[2]  M. Bassetti,et al.  Linezolid in the treatment of Gram-positive prosthetic joint infections. , 2005, The Journal of antimicrobial chemotherapy.

[3]  R. Suchland,et al.  Differential Regulation of Inflammatory Cytokine Secretion by Human Dendritic Cells upon Chlamydia trachomatis Infection , 2004, Infection and Immunity.

[4]  Jerome J. Schentag,et al.  Linezolid in the Treatment of Osteomyelitis: Results of Compassionate Use Experience , 2004, Infection.

[5]  J. Lonner,et al.  Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. , 2003, The Journal of arthroplasty.

[6]  F. Aoki,et al.  Glycoprotein-D-adjuvant vaccine to prevent genital herpes. , 2002, The New England journal of medicine.

[7]  Robert E. Johnson,et al.  Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. , 2002, The Journal of infectious diseases.

[8]  R. Peeling,et al.  Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. , 2002, The Journal of infectious diseases.

[9]  M. Bassetti,et al.  Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA) , 2000, Journal of Orthopaedics and Traumatology.

[10]  M. J. Morlius,et al.  Tratamiento antibiótico por vía oral de la osteomielitis bacteriana del adulto: resultados tras dos años de seguimiento , 1999 .

[11]  T. Rohan,et al.  Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction. , 1999, Molecular and cellular probes.

[12]  D. Raoult,et al.  Ambulatory Treatment of Multidrug-ResistantStaphylococcus-Infected Orthopedic Implants with High-Dose Oral Co-trimoxazole (Trimethoprim-Sulfamethoxazole) , 1998, Antimicrobial Agents and Chemotherapy.

[13]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[14]  A. Hanssen,et al.  Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  C. Jones,et al.  Cervical cancer: is herpes simplex virus type II a cofactor? , 1995, Clinical microbiology reviews.

[16]  R. Whitley,et al.  Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. , 1995, The Journal of infectious diseases.

[17]  Mey-Fann Lee,et al.  Detection of Human Papillomavirus Types in Cervical Lesions of Patients from Taiwan by the Polymerase Chain Reaction , 1994, Sexually transmitted diseases.

[18]  D. Raoult,et al.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants , 1993, Antimicrobial Agents and Chemotherapy.

[19]  A. Widmer,et al.  Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  B. Morrey,et al.  Treatment of infection after total knee arthroplasty by débridement with retention of the components. , 1990, The Journal of bone and joint surgery. American volume.

[21]  T S Thornhill,et al.  Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. , 1990, The Journal of bone and joint surgery. American volume.

[22]  S. Amyes,et al.  The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. , 1989, Journal of medical microbiology.

[23]  M. Lehtinen,et al.  Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. , 2003, American journal of obstetrics and gynecology.

[24]  G. Löwhagen,et al.  Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. , 2002, Acta dermato-venereologica.

[25]  T. Bjørge,et al.  Chlamydia trachomatis infection as a risk factor for invasive cervical cancer , 2000, International journal of cancer.

[26]  M. Javaloyas de Morlius,et al.  [Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up]. , 1999, Medicina clinica.